Free fillable PDF + editable Word

Hyaluronic acid filler consent

An HA filler consent discussion needs the actual product, injection site, expected benefit and product-specific patient information. The possibility of serious vascular injury deserves explicit discussion rather than being hidden in a generic cosmetic release.

Prepared by Prospyr · Sources checked September 21, 2026 · Version 2.0

Get the free PDF + Word template →

Know the boundaries

Not for: Permanent fillers, biostimulatory fillers, silicone, body contouring, or a promise that filler is fully reversible.

Source-checked template, version 2.0, September 21, 2026. Practice review and adaptation are required before use. No independent clinician or attorney approval is claimed. Adult patient self-consent only; use a separately reviewed process for minors or representatives.

Inside the template

Two clean, unbranded patient-facing pages: the relevant discussion, specific choices and completion fields, and the patient decision with signatures. The PDF includes fillable fields and selection controls where applicable. Use the Word version to adapt the language. Sources and practice guidance stay on this page. Typed fields are not a verified electronic-signature service.

Sample patient discussion page from the hyaluronic acid filler consent

Actual sample page · Open to enlarge · Full editable files available below

Prepare your practice version

  1. Attach the patient labeling for the exact product and check the planned anatomical site.
  2. Explain common effects and serious vascular complications.
  3. Record previous filler, allergies, medicines and individualized risks.
  4. Document the urgent assessment route and discuss the limits and risks of any corrective treatment.

Public text preview

Language for the conversation

Expected local effects

Pain, tenderness, swelling, bruising, redness, itching and temporary unevenness can occur. Recovery and results vary by product, area and individual response.

Other complications

Infection, allergic reactions, lumps or nodules, inflammation, migration, open wounds, scarring, asymmetry and an unwanted appearance are possible. Some reactions may arise weeks, months or years later.

Blood-vessel injury

Filler can unintentionally enter or block a blood vessel. This can injure skin and other tissue and may cause tissue death, permanent scarring, blindness or stroke. Rapid assessment may be needed; a good outcome cannot be guaranteed.

Details to complete before signing

  • Practice name
  • Visit / discussion date
  • Patient full name
  • Date of birth
  • Treating clinician
  • Treatment date
  • Exact product / device, planned treatment areas and intended benefit
  • Patient labeling / instructions reviewed (version)
  • Proposed use: labeled / off-label (explain)
  • Any off-label use and its reason, uncertainties and alternatives discussed
  • Relevant history, medicines, allergies and patient-specific risks / plan
  • Alternatives discussed and patient questions / answers
  • Written aftercare / patient information supplied
  • Follow-up plan
  • Urgent practice contact
  • After-hours contact / instructions
  • Patient signature
  • Date / time
  • Clinician / practice representative name
  • Signature / date
  • Interpreter name / ID if used
  • Language
  • Copy of completed consent provided by
  • Date / method

Common questions

Is this a consent for every dermal filler?

No. Its scope is hyaluronic acid fillers. The treating clinician must add the specific product labeling, site risks and patient factors. Other filler materials need a different review.

Does the form waive responsibility for complications?

No. It records a discussion and voluntary decision; it is not a liability waiver or guarantee of an outcome.

Source map and review status

How Prospyr checks sources and handles corrections

This is an original draft synthesized from the authorities below, not a government-issued form or a copied competitor document. References support the stated scope and risk discussion; they do not certify this template. No attorney or clinician approval has been obtained.

Before implementation

  • Confirm state-specific consent, privacy, professional-scope and record-retention requirements with counsel.
  • Have the clinical or privacy lead review every clause, complete all practice fields and remove inapplicable options before release.
  • Provide accessible language and an interpreter when needed; allow questions and a voluntary decision.
  • Store the approved version and completed document in the authorized patient-record system. Never send completed patient forms to this website.
  • Record the approving professional, approval date, version and next review date. Recheck after changes to law, labeling or practice workflow.

Version history: 2.0 · September 21, 2026 · Rebuilt as a neutral patient form after reviewing blank production consent definitions. Version 1.0 was published September 20, 2026.

Report a source update or correction

Put the approved form into your workflow.

Connect digital intake, patient records and practice operations with Prospyr. Bring your reviewed forms and see how the workflow fits your team.

See Prospyr in action →

More from the consent library